Results 71 to 80 of about 674,512 (170)

End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice [PDF]

, 2011
Howard I. Scher, Michael J. Morris, Ethan Basch, Glenn Heller   +3 more
openalex   +1 more source

Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated Destruction. [PDF]

Clin Cancer Res
Blinka S, Yu EY.
europepmc   +1 more source

PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer

Haixia He, Qianghua Zhou, Yanjie Zhang, Yi Li, Lin Ding, Ting Shen, Sen Liu, Shengmeng Peng, Ming Huang, Hua Zhou, Liang Cheng, Ruihui Xie, Qiang Zhang, Junlin Lu, Liting Li, Jing Yang, Shoumin Bai, Tianxin Lin, Xu Chen   +18 more
openalex   +1 more source

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden. [PDF]

Cancer Epidemiol Biomarkers Prev
Lin E, Garmo H, Beckmann K, Bratt O, Stattin P, Gedeborg R.   +5 more
europepmc   +1 more source

Deep Learning Treatment Recommendations for Patients Diagnosed with Non-Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Deprivation Treatment [PDF]

Chunyang Li, Julia Bohman, Vikas Patil, Richard Mcshinsky, Christina Yong, Zachary Burningham, Matthew Samore, Ahmad Halwani   +7 more
openalex   +1 more source

Learning from prostate cancer statistics. [PDF]

CA Cancer J Clin
Etzioni R, Owens L.
europepmc   +1 more source

Prostate Cancer Before 50: A Wake-Up Call [PDF]

Puneet Kumar Bagri, Kapil Chaudhary, Himanshi Avinash Jain, Amruta Tripathy   +3 more
openalex   +1 more source

Identification of progression markers for prostate cancer. [PDF]

Cell Cycle
Song J, Zhou Y, Hedman H, Rantapero T, Landström M.   +4 more
europepmc   +1 more source

PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer [PDF]

, 2013
Hyeongsun Moon, Cheok Soon Lee, Kerry L. Inder, Sowmya Sharma, Eun‐Ju Choi, Debra Black, Kim‐Anh Lê Cao, Clay Winterford, Jermaine Coward, Ming‐Tat Ling, David J. Craik, Robert G. Parton, Pamela J. Russell, Michelle M. Hill   +13 more
openalex   +1 more source

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy [PDF]

, 2008
John Pendleton, Winston Tan, Satoshi Anai, Myron Chang, Wei Hou, Kathleen T. Shiverick, Charles J. Rosser   +6 more
openalex   +1 more source